本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

10.22
-0.4700-4.40%
盤後8.90-1.3200-12.92%19:59 EDT
成交量:101.33萬
成交額:1,035.28萬
市值:8.91億
市盈率:-4.80
高:10.86
開:10.79
低:10.18
收:10.69
52周最高:36.26
52周最低:6.65
股本:8,715.70萬
流通股本:7,188.81萬
量比:1.27
換手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
淨資產收益率:-52.74%
總資產收益率:-31.82%
市淨率:2.07
市盈率(LYR):-5.47

資料載入中...

2025/03/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/19

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/19

重要事件披露

Form 8-K - Current report
2025/03/05

重要事件披露

Form 8-K - Current report
2025/01/13

SEC問詢函

Form CORRESP - Correspondence
2025/01/13

SEC問詢函

Form CORRESP - Correspondence
2025/01/13

重要事件披露

Form 8-K - Current report
2025/01/10

重要事件披露

Form 8-K - Current report
2024/12/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities